Identifying risk factors for aggressive melanoma in veterans

Risk Factors for Clinically Aggressive Melanoma in Veterans

['FUNDING_OTHER'] · VA BOSTON HEALTH CARE SYSTEM · NIH-10975905

This study is looking at what makes melanoma more aggressive in veterans over 65, and it aims to create a helpful tool to spot the disease earlier and improve treatment, so veterans can get better care tailored to their needs.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorVA BOSTON HEALTH CARE SYSTEM (nih funded)
Locations1 site (BOSTON, UNITED STATES)
Trial IDNIH-10975905 on ClinicalTrials.gov

What this research studies

This research investigates the risk factors associated with clinically aggressive melanoma in veterans, particularly those aged 65 and older. The study aims to develop and validate a clinical risk prediction model that incorporates both genetic and phenotypic factors to improve early detection and treatment outcomes. By analyzing various demographics, co-morbidities, and environmental exposures, the research seeks to create personalized screening approaches that can be easily implemented in clinical settings. The ultimate goal is to enhance melanoma screening and reduce the burden of this disease among veterans.

Who could benefit from this research

Good fit: Ideal candidates for this research are veterans aged 65 and older who may be at risk for developing clinically aggressive melanoma.

Not a fit: Patients who are younger than 65 or those without a history of melanoma or significant risk factors may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved early detection and treatment of aggressive melanoma, potentially saving lives and reducing healthcare costs.

How similar studies have performed: Previous research has shown promise in developing risk prediction models for melanoma, indicating that this approach could be effective.

Where this research is happening

BOSTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.